I have previously written about Arcadia Biosciences (RKDA), most recently arguing that while imminent revenues are very important, the long-term value in the stock will arise from its technology platform. That argument still holds true, but now in addition to fundamental factors, I think there exist timing factors which could make holding RKDA an excellent trade in the shorter term. I will delve into these in the bulk of this article, but will begin by reviewing some recent positive company developments.
Recent Developments
D1. New CEO And An Investor-Friendly Approach
Though some might